212 related articles for article (PubMed ID: 24789077)
1. Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.
Hua G; Liu Y; Li X; Xu P; Luo Y
Oncol Rep; 2014 Jun; 31(6):2727-34. PubMed ID: 24789077
[TBL] [Abstract][Full Text] [Related]
2. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin.
Song YD; Zhang KF; Liu D; Guo YQ; Wang DY; Cui MY; Li G; Sun YX; Shen JH; Li XG; Zhang L; Shi FJ
Tumour Biol; 2014 Jul; 35(7):7017-24. PubMed ID: 24748236
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.
Hsieh MJ; Huang C; Lin CC; Tang CH; Lin CY; Lee IN; Huang HC; Chen JC
Mol Carcinog; 2020 Mar; 59(3):293-303. PubMed ID: 31916307
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
Chen JC; Huang C; Lee IN; Wu YP; Tang CH
Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
[TBL] [Abstract][Full Text] [Related]
6. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin.
Chen JC; Shih HC; Lin CY; Guo JH; Huang C; Huang HC; Chong ZY; Tang CH
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614283
[TBL] [Abstract][Full Text] [Related]
8. Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets.
Nazeri E; Gouran Savadkoohi M; Majidzadeh-A K; Esmaeili R
Crit Rev Oncol Hematol; 2018 Nov; 131():102-109. PubMed ID: 30293700
[TBL] [Abstract][Full Text] [Related]
9. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro.
Lechler P; Renkawitz T; Campean V; Balakrishnan S; Tingart M; Grifka J; Schaumburger J
BMC Cancer; 2011 Apr; 11():120. PubMed ID: 21457573
[TBL] [Abstract][Full Text] [Related]
10. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Cleton-Jansen AM; van Beerendonk HM; Baelde HJ; Bovée JV; Karperien M; Hogendoorn PC
Clin Cancer Res; 2005 Nov; 11(22):8028-35. PubMed ID: 16299232
[TBL] [Abstract][Full Text] [Related]
11. Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.
Gallego B; Murillo D; Rey V; Huergo C; Estupiñán Ó; Rodríguez A; Tornín J; Rodríguez R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742867
[TBL] [Abstract][Full Text] [Related]
12. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
14. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
[TBL] [Abstract][Full Text] [Related]
15. Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells.
Liang W; Li X; Li Y; Li C; Gao B; Gan H; Li S; Shen J; Kang J; Ding S; Lin X; Liao L
Int J Oncol; 2014 Jan; 44(1):91-8. PubMed ID: 24173143
[TBL] [Abstract][Full Text] [Related]
16. Functional roles of CSPG4/NG2 in chondrosarcoma.
Jamil NS; Azfer A; Worrell H; Salter DM
Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
[TBL] [Abstract][Full Text] [Related]
17. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
[TBL] [Abstract][Full Text] [Related]
18. No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
Peterse EF; Cleven AH; De Jong Y; Briaire-de Bruijn I; Fletcher JA; Danen EH; Cleton-Jansen AM; Bovée JV
BMC Cancer; 2016 Jul; 16():475. PubMed ID: 27418340
[TBL] [Abstract][Full Text] [Related]
19. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo.
Chen C; Zhou H; Xu L; Xu D; Wang Y; Zhang Y; Liu X; Liu Z; Ma D; Ma Q; Chen Y
Apoptosis; 2010 Jul; 15(7):805-13. PubMed ID: 20349137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
